Arrowhead Pharmaceuticals, Inc.

NasdaqGS:ARWR Stock Report

Market Cap: US$2.7b

Arrowhead Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ARWR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Apr 24SellUS$168,180James HamiltonIndividual6,000US$28.03
20 Mar 24BuyUS$82,990Hongbo LuIndividual3,000US$28.00
06 Mar 24SellUS$1,407,600Kenneth MyszkowskiIndividual40,000US$35.19
20 Nov 23SellUS$567,315Javier San MartinIndividual19,700US$29.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ARWR?
Owner TypeNumber of SharesOwnership Percentage
State or Government75,2480.0605%
Individual Insiders4,866,2523.91%
Hedge Funds8,888,8887.15%
General Public19,697,16115.8%
Institutions90,787,72573%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16%.


Top Shareholders

Top 25 shareholders own 68.62% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
BlackRock, Inc.
15,683,206US$334.7m2.19%0.01%
9.83%
The Vanguard Group, Inc.
12,214,101US$260.6m-1.53%no data
7.15%
Avoro Capital Advisors LLC
8,888,888US$189.7m3.9%2.22%
5.48%
FMR LLC
6,810,929US$145.3m6.52%0.01%
5.11%
State Street Global Advisors, Inc.
6,354,331US$135.6m8.85%no data
3.33%
Slate Path Capital LP
4,139,000US$88.3m0%1.59%
2.99%
Christopher Anzalone
3,715,048US$79.3m0%no data
2.57%
Artal Group S.A.
3,189,389US$68.1m5.03%1.43%
2.36%
Geode Capital Management, LLC
2,937,948US$62.7m6.65%no data
2.12%
UBS Asset Management AG
2,638,458US$56.3m90.5%0.01%
2.12%
T. Rowe Price Group, Inc.
2,634,731US$56.2m44%no data
1.49%
JP Morgan Asset Management
1,857,017US$39.6m-21.5%no data
1.31%
Morgan Stanley, Investment Banking and Brokerage Investments
1,630,188US$34.8m74.2%no data
1.28%
Norges Bank Investment Management
1,585,320US$33.8m19.9%no data
1.07%
Credit Suisse Asset Management (Switzerland) Ltd.
1,332,032US$28.4m0%0.03%
1.06%
Northern Trust Global Investments
1,322,718US$28.2m1.7%no data
0.9%
Goldman Sachs Group, Investment Banking and Securities Investments
1,122,960US$24.0m28.2%0.01%
0.87%
BNY Asset Management
1,076,940US$23.0m2.79%no data
0.8%
Charles Schwab Investment Management, Inc.
994,361US$21.2m0%no data
0.76%
Citadel Advisors LLC
948,444US$20.2m27.8%0.02%
0.76%
Rokos Capital Management LLP
939,984US$20.1m-23.5%0.43%
0.73%
Aquilo Capital Management, LLC
908,474US$19.4m0%18.61%
0.66%
Woodline Partners LP
821,518US$17.5m47.9%0.16%
0.66%
Western Financial Corporation
820,239US$17.5m0%9.39%
0.6%
Pictet Asset Management Limited
743,684US$15.9m-39.3%0.01%